Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

IRP2 contributes to COPD-associated hypoxic epithelial injury through regulation of Sestrin2-related stress responses and ferroptosis.

Created on 19 Oct 2026

Authors

Chunyan Xiong, Min Song, Tianshu He, Yao Ma, Jiang Wang

Published in

Cytotechnology. Volume 78. Issue 6. Pages 214. Epub Oct 17, 2026.

Abstract

Chronic obstructive pulmonary disease (COPD) is characterized by persistent oxidative stress and airway epithelial injury. However, the molecular mechanisms linking iron metabolism and cellular stress responses in COPD remain unclear. This study aimed to investigate the role of iron regulatory protein 2 (IRP2) in COPD-associated epithelial injury. 16HBE and A549 cells were exposed to cigarette smoke extract (CSE) under a COPD-associated hypoxic microenvironment. IRP2 was silenced using shRNA, and Sestrin2 restoration experiments were performed. Cellular injury was evaluated by cell viability, ROS production, inflammatory cytokines, intracellular Fe²⁺ accumulation, ferroptosis-related proteins, and NRF2 activation. CSE exposure under a COPD-associated hypoxic microenvironment induced epithelial injury, accompanied by increased oxidative stress, inflammation, iron accumulation, and ferroptosis-related changes. IRP2 silencing alleviated these alterations and enhanced NRF2 nuclear activation with increased expression of antioxidant proteins. Restoration of Sestrin2 partially reversed the protective effects induced by IRP2 depletion. Furthermore, pharmacological inhibition of ferroptosis attenuated epithelial injury. IRP2 contributes to COPD-associated epithelial injury by regulating oxidative stress, iron homeostasis, and ferroptosis-related responses, providing new insights into the molecular mechanisms underlying COPD progression.
The online version contains supplementary material available at https://doi.org/10.1007/s10616-026-01066-9.

PMID:
42894591
Bibliographic data and abstract were imported from PubMed on 19 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 12
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement